10/9
02:01 am
glmd
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/1
02:07 am
glmd
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/25
08:00 am
glmd
Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology
High
Report
Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology
9/23
02:07 am
glmd
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Neutral
Report
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/19
07:00 am
glmd
Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases
High
Report
Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases
9/15
05:02 am
glmd
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/7
02:08 am
glmd
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.